- Home
- DOMO vs MGTX Comparison
DOMO vs MGTX Comparison
Compare DOMO & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOMO
- MGTX
- Stock Information
- Founded
- DOMO 2010
- MGTX 2015
- Country
- DOMO United States
- MGTX United States
- Employees
- DOMO N/A
- MGTX N/A
- Industry
- DOMO Computer Software: Prepackaged Software
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DOMO Technology
- MGTX Health Care
- Exchange
- DOMO Nasdaq
- MGTX Nasdaq
- Market Cap
- DOMO 707.1M
- MGTX 670.2M
- IPO Year
- DOMO 2018
- MGTX N/A
- Fundamental
- Price
- DOMO $14.67
- MGTX $8.31
- Analyst Decision
- DOMO Buy
- MGTX Strong Buy
- Analyst Count
- DOMO 8
- MGTX 2
- Target Price
- DOMO $15.13
- MGTX $24.00
- AVG Volume (30 Days)
- DOMO 758.2K
- MGTX 340.8K
- Earning Date
- DOMO 08-27-2025
- MGTX 11-12-2025
- Dividend Yield
- DOMO N/A
- MGTX N/A
- EPS Growth
- DOMO N/A
- MGTX N/A
- EPS
- DOMO N/A
- MGTX N/A
- Revenue
- DOMO $318,363,000.00
- MGTX $37,917,000.00
- Revenue This Year
- DOMO $2.28
- MGTX $144.79
- Revenue Next Year
- DOMO $2.29
- MGTX $168.58
- P/E Ratio
- DOMO N/A
- MGTX N/A
- Revenue Growth
- DOMO N/A
- MGTX 366.84
- 52 Week Low
- DOMO $6.01
- MGTX $3.97
- 52 Week High
- DOMO $18.49
- MGTX $8.98
- Technical
- Relative Strength Index (RSI)
- DOMO 38.48
- MGTX 57.15
- Support Level
- DOMO $14.98
- MGTX $8.20
- Resistance Level
- DOMO $15.68
- MGTX $8.68
- Average True Range (ATR)
- DOMO 0.73
- MGTX 0.41
- MACD
- DOMO -0.30
- MGTX 0.04
- Stochastic Oscillator
- DOMO 7.64
- MGTX 65.67
About DOMO Domo Inc. Class B
Domo Inc provides a cloud-based platform that digitally connects all the data, systems, and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.